hematoxylin has been researched along with Wallerian Degeneration in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bechmann, I; Gimsa, U; Lossau, S; Mor, G; Nitsch, R; Steiner, B | 1 |
1 other study(ies) available for hematoxylin and Wallerian Degeneration
| Article | Year |
|---|---|
Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration.
Topics: Animals; Apoptosis; Astrocytes; Cell Nucleus; Cytoskeletal Proteins; Denervation; Entorhinal Cortex; Fas Ligand Protein; fas Receptor; Glial Fibrillary Acidic Protein; Hematoxylin; In Situ Nick-End Labeling; Membrane Glycoproteins; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Wallerian Degeneration | 2000 |